Neurelis
Developing and commercializing nasal spray treatments for neurological disorders.
Company facts
- Founded
- 2007
- Employees
- 184
- Headquarters
- United States
- Type
- Private
- Funding
- Series D · $114M · 2021
- Subsidiaries
- Aegis Therapeutics
Developing and commercializing nasal spray treatments for neurological disorders.
Company facts